+7 (495) 796-94-33

Cart

Address: Moscow, Skolkovo

Bolshoy bulvar, 42 b1 Lab. 3A, 08. 559

view the map

Publications

Review of Pharmacoeconomic Studies in Radionuclide Therapy of Painful Bone Metastases

Voloznev L.V.

IJNMR-S1A9-Lev

International Journal of Nuclear Medicine Research, Special Issue – July-2017 – p101-106

Differences in applying radiopharmaceuticals to treat metastatic bone cancer

Krilov V.V., Kochetova T.U., Belozerova M.S., Voloznev L.V.

Palliamed. 2015. — №4. — С.26-34

Okteotid, 111in diagnosing and treating medullary thyroid cancer

Reshetov I.V., Mirzoyanc S.G., Shevalgin A.A.

HEAD & NECK. Russian Journal — 2015. — №2. — С.18-

188Re-Zoledronic acid — new Russian radiopharmaceutical for therapeutic purposes. First clinical trial

Kochetova T.Y., Krilov V.V., Smoliarchuk M.IA., Voloznev L.V., Lynev A.S.

Oncology bulletin of the Volga region – 2014. – №3. – С.41-47

Clinical trial of applying Rezoscan 99mТс in diagnosing damaged metastatic bone tissue

Znamensky I. A., Servyli E.A., Strabikina D.S., Kondakov A.K., Mosin D.U.

Onkologiya. Zhurnal imeni P.A. Gertsena – 2013. – №3. – С.69-72

Developmental mechanisms of metastatic damaged skeleton and theraupetic role of N- Bisphosphonates

Voloznev L.V.

Onkologiya. Zhurnal imeni P.A. Gertsena– 2013. – №1. – С. 73-77

Experimental evaluation of functional application of 188Re-Zoledronic acid

Voloznev L.V., Klementeva O.E., Korsunskiy V. N., Lisenko N.P.

Molecular medicine – 2013. – №2. – С. 42-45.

Safety evaluation and dosage of a 188Re-Zoledronic acid in a clinical trial

Voloznev L.V., Lunev A.S., Klementeva O.E., Korsunskiy V. N.

MEDITSINSKAYA FIZIKA (Medical Physics) – 2013. – №2. – С. 83-8

Labeled by the Zoledronic acid radiopharmaceuticals for metastatic bone cancer patients

Fomin D.K., Lugai O.O., Nazarov A.A.

Onkologiya. Zhurnal imeni P.A. Gertsena – 2012. – №2. – С.66-68

Preparation and biodistribution of 99mTc and 188Re labelled zoledronic acid

Klementyeva O., Malysheva A., Kodina G., Korsunsky V., Rabinovich E., Voloznev L., Krylov V.

World Journal of Nuclear Medicine. – 2012. – V. 11(3). – P. 177.

Experimental evaluation of Octreotide that has been labeled by Indium-111 for Radionuclide Diagnostics of Tumors with High Expression of Somatostatin Receptors

Grinin M.G., Shimanovki N.L.

Experimental and Clinical Pharmacology. – 2011. – Т.74(9). – С.23-27

New radiopharmaceutical Rezoscan 99mTc for diagnosing skeletal lesions in prostate cancer patients

Apolihin O.I., Sivkov A.V., Oschepkov V.N., etc.

Experimental and Clinical Urology —2010. — № 1. — С. 43-48.

Potential application of a radiopharmaceutical Okteotide 111In in oncological practice

Solodkiu V.A., Ivanova V.V., Panishin G.A., Stavitskiu R.V.

Radiology – Practice. – 2010.– №4. – С.42-48